CNBX PHARMACEUTICALS INC. OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax
CNBX PHARMACEUTICALS INC. (CNBX) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax of $76.34 thousand for the 3-month period ending 2020-05-31, per its 10-Q filed 2020-07-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax · last filed 2020-07-14
- CNBX PHARMACEUTICALS INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2020-05-31 was $76.34K, a 92.27% decline year-over-year.
- CNBX PHARMACEUTICALS INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2020-02-29 was -$2.14M, a 143.90% decline year-over-year.
- CNBX PHARMACEUTICALS INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2019-05-31 was $987.10K.
- CNBX PHARMACEUTICALS INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2019-02-28 was $4.88M.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 6 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 9 month |
|---|---|---|---|
| 2020-05-31 | $76.34K 10-Q · filed 2020-07-14 | -$2.07M derived: sum of 2 quarters · filed 2020-07-14 | -$5.58M 10-Q · filed 2020-07-14 |
| 2020-02-29 | -$2.14M 10-Q · filed 2020-04-13 | -$5.65M 10-Q · filed 2020-04-13 | |
| 2019-05-31 | $987.10K 10-Q · filed 2020-07-14 | $5.87M derived: sum of 2 quarters · filed 2020-07-14 | $5.87M 10-Q · filed 2020-07-14 |
| 2019-02-28 | $4.88M 10-Q · filed 2020-04-13 | $4.88M 10-Q · filed 2020-04-13 |